Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.scs.2020.102446 http://scihub22266oqcxt.onion/10.1016/j.scs.2020.102446 32837871!7428766!32837871     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Sustain+Cities+Soc 2021 ; 65 (ä): 102446 Nephropedia Template TP {{tp|p=32837871|t=2021. SARS-CoV-2 presented in the air of an intensive care unit (ICU) |pdf=|usr=}}{{32837871}} gab.com Text SARS-CoV-2 presented in the air of an intensive care unit (ICU) JO: Sustain Cities Soc http://www.kidney.de/pget.php?&tw=1&pmid=32837871 #FOAvip As coronavirus disease 2019 (COVID-19) is spreading worldwide, there have been arguments regarding the aerosol transmission of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, some re-detectable positive (RP) patients have been reported. However, little attention has been given to the follow-up of recovered patients, and there is no environmental evidence to determine whether these patients continue to shed the virus after they test negative. Therefore, with an objective to test the hypothesis of airborne transmission of SARS-CoV-2, it is necessary to 1) determine whether SARS-CoV-2 particles are present in the indoor air and 2) determine whether recovered patients are still shedding virus, thus providing much-needed environmental evidence for the management of COVID-19 patients during the recovery period. In this study, surface and air samples were collected from an intensive care unit (ICU) containing one ready-for-discharge patient. All surface samples tested negative, but the air samples tested positive for SARS-CoV-2. This implies that SARS-CoV-2 particles may be shed in aerosol form for days after patients test negative. This finding may be one of the reasons for the observation of RP patients; therefore, there is a need for improved clinical and disease management guidelines for recovered COVID-19 patients. Twit Text FOAVip SARS-CoV-2 presented in the air of an intensive care unit (ICU) ????Sustain Cities Soc http://www.kidney.de/pget.php?&tw=1&pmid=32837871 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32837871 #FOAvip English Wikipedia <ref>{{Cite pmid|32837871}}</ref> SARS-CoV-2 presented in the air of an intensive care unit (ICU) #MMPMID32837871 Jin T; Li J; Yang J; Li J; Hong F; Long H; Deng Q; Qin Y; Jiang J; Zhou X; Song Q; Pan C; Luo P Sustain Cities Soc 2021[Feb]; 65 (ä): 102446 PMID32837871show ga As coronavirus disease 2019 (COVID-19) is spreading worldwide, there have been arguments regarding the aerosol transmission of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, some re-detectable positive (RP) patients have been reported. However, little attention has been given to the follow-up of recovered patients, and there is no environmental evidence to determine whether these patients continue to shed the virus after they test negative. Therefore, with an objective to test the hypothesis of airborne transmission of SARS-CoV-2, it is necessary to 1) determine whether SARS-CoV-2 particles are present in the indoor air and 2) determine whether recovered patients are still shedding virus, thus providing much-needed environmental evidence for the management of COVID-19 patients during the recovery period. In this study, surface and air samples were collected from an intensive care unit (ICU) containing one ready-for-discharge patient. All surface samples tested negative, but the air samples tested positive for SARS-CoV-2. This implies that SARS-CoV-2 particles may be shed in aerosol form for days after patients test negative. This finding may be one of the reasons for the observation of RP patients; therefore, there is a need for improved clinical and disease management guidelines for recovered COVID-19 patients. äSARS-CoV-2 presented in the air of an intensive care unit (ICU) (epmc).pdf DeepDyve Pubget Overpricing